This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Endometriosis is a common ailment estimated to affect 12% of reproductive-aged women and up to 80% of women with chronic pelvic pain. Standard medical and surgical treatments used to treat women with endometriosis are insufficient because many women do not get adequate relief of their pain and pain often returns even if they initially responded to treatment. Despite the high frequency and often negative impact on women's lives, little is known about why and how some, but not all, women with endometriosis develop chronic pelvic pain. A variety of possibilities have been explored with numerous studies failing to find an association between pain symptoms and the extent or spread of the endometriosis implants. Pain in other chronic pain syndromes, such as irritable bowel syndrome, fibromyalgia, temporomandibular disorders, and vulvodynia, has been shown to be related to abnormalities in the way the brain processes and interprets pain, rather than from direct damage or inflammation of specific organs or tissues. A common finding in these pain syndromes is increased tenderness to pressure, even far away from the primary site of pain symptoms. Successful treatment of these chronic pain disorders often includes medications that improve the way the brain processes and interprets pain. Preliminary research in a small number of women with endometriosis and chronic pelvic pain suggests that abnormalities in pain processing may also be a problem in this condition. If such abnormalities are confirmed in women with endometriosis-associated chronic pelvic pain, this could result in a paradigm shift in the treatment of this condition. In addition to therapies aimed at suppressing or excising endometriosis implants (i.e. hormonal medications and/or surgery), some women may also benefit from treatments aimed at correcting abnormalities in pain processing. Thus, the overall purpose of this research study is to better understand the cause of chronic pelvic pain in women with endometriosis.
The specific aims of this study are to describe the spectrum of physical, biochemical, and psychological function of women with endometriosis and determine whether an abnormality in pain processing occurs in a subset of women with endometriosis-associated chronic pelvic pain. The study involves a medical interview and examination, filling out several questionnaires, a blood draw, and a brief pain testing session.'

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000042-47
Application #
7603837
Study Section
Special Emphasis Panel (ZRR1-CR-8 (02))
Project Start
2007-03-01
Project End
2007-09-16
Budget Start
2007-03-01
Budget End
2007-09-16
Support Year
47
Fiscal Year
2007
Total Cost
$6,328
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419
Spengler, Erin K; Kleiner, David E; Fontana, Robert J (2017) Vemurafenib-induced granulomatous hepatitis. Hepatology 65:745-748
Heidemann, Lauren; Law, James; Fontana, Robert J (2017) A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury. Dig Dis Sci 62:615-625
Kadakia, Kunal C; Snyder, Claire F; Kidwell, Kelley M et al. (2016) Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer. Oncologist 21:539-46
Ricker, Charité; Culver, Julie O; Lowstuter, Katrina et al. (2016) Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genet 209:130-7
Law, Ian H; Alam, Osman; Bove, Edward L et al. (2016) Follow-Up of a Prospective Surgical Strategy to Prevent Intra-Atrial Reentrant Tachycardia After the Fontan Operation. Circ Arrhythm Electrophysiol 9:

Showing the most recent 10 out of 1380 publications